The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Balcom Alexandra since 2023.
This trader's CIK number is 1862147.
At the time of last reporting, Balcom Alexandra was the Chief Financial Officer of Nuvalent, Inc.. (stock ticker symbol NUVL).
Also see all insider trading activities at Nuvalent, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NUVL | 0 | $0 | 24,016 | $1,919,202 | 20,000 | $378,600 |
| 2024 | NUVL | 0 | $0 | 50,000 | $4,469,520 | 63,700 | $1,447,094 |
| 2023 | NUVL | 0 | $0 | 55,000 | $3,500,850 | 55,000 | $59,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-27 | NUVL | Option Ex | 20,000 | 18.93 | 378,600 |
| 2025-06-27 | NUVL | Sale | 20,000 | 80.02 | 1,600,400 |
| 2025-01-06 | NUVL | Sale | 4,016 | 79.38 | 318,802 |
| 2024-12-17 | NUVL | Option Ex | 13,700 | 3.98 | 54,594 |
| 2024-11-29 | NUVL | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-11-29 | NUVL | Sale | 10,000 | 95.97 | 959,700 |
| 2024-10-31 | NUVL | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-10-31 | NUVL | Sale | 10,000 | 89.67 | 896,680 |
| 2024-09-30 | NUVL | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-09-30 | NUVL | Sale | 10,000 | 100.50 | 1,004,980 |
| 2024-08-30 | NUVL | Sale | 10,000 | 84.79 | 847,930 |
| 2024-08-30 | NUVL | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-06-28 | NUVL | Option Ex | 10,000 | 27.85 | 278,500 |
| 2024-06-28 | NUVL | Sale | 10,000 | 76.02 | 760,230 |
| 2023-12-18 | NUVL | Option Ex | 30,000 | 1.08 | 32,400 |
| 2023-12-18 | NUVL | Sale | 30,000 | 75.82 | 2,274,600 |
| 2023-07-31 | NUVL | Option Ex | 25,000 | 1.08 | 27,000 |
| 2023-07-31 | NUVL | Sale | 25,000 | 49.05 | 1,226,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Balcom Alexandra (Chief Financial Officer of Nuvalent, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.